| Cat. No. |
Product Name |
Information |
| PC-62050 |
LJ001
Viral entry inhibitor
|
LJ001 ((LJ-001) is a broad-spectrum antiviral agent targeting entry of enveloped viruses, including influenza A, filoviruses, poxviruses, arenaviruses, bunyaviruses, paramyxoviruses, flaviviruses, and HIV-1. |
| PC-61648 |
Gliocidin
IMPDH2 inhibitor, Influenza inhibitor
|
Gliocidin (SW106065) is a broad influenza virus inhibitor acting via IMP dehydrogenase (IMPDH), also is an apoptosis inducer in MPNST (malignant peripheral nerve sheath tumors) with EC50 of 1 uM. |
| PC-70358 |
M2WJ-332
Influenza inhibitor
|
M2WJ-332 is a potent inhibitor of drug-resistant S31N mutant of the M2 ion channel of influenza A virus with IC50 of 153 nM. |
| PC-45139 |
Peramivir
|
Peramivir (RWJ-270201, BCX-1812) is an inhibitor of influenza neuraminidase that prevents new viral particles from being released. |
| PC-45138 |
Peramivir trihydrate
|
Peramivir (RWJ-270201, BCX-1812) is an inhibitor of influenza neuraminidase that prevents new viral particles from being released. |
| PC-45819 |
Nucleozin
Influenza NP inhibitor
|
Nucleozin is a small-molecule influenza A nucleoprotein (NP) inhibitor that triggers the aggregation of NP and inhibits its nuclear accumulation. |
| PC-24187 |
Suraxavir marboxil
Infuenza PA Inhibitor
|
Suraxavir marboxil (GP681) is an orally bioavailable antiviral drug inhibiting the polymerase acidic protein (PA) of RNA polymerase of influenza virus, demonstrates nanomolar antiviral activity against both influenza A and B viruses with the average IC50 on the transcriptional activity of 0.6 nM, EC90 of 6.9 ng/mL. |
| PC-22911 |
Riamilovir
Antiviral agent
|
Riamilovir is a nucleoside analogue, broad-spectrum antiviral agent targeting influenza viruses, lassa virus, TBEV and Ebola virus.
Triazavirin suppresses the replication of influenza virus in cell culture and in chicken chorioallantoic membranes, and protects mice from death caused by type A and B influenza viruses. |
| PC-22716 |
BPR3P0128
Viral RdRp inhibitor
|
BPR3P0128 is a potent, non-nucleoside viral RNA-dependent RNA polymerase (RdRp) inhibitor with EC05 of 0.66 uM, inhibits influenza viral replication with IC50 of 51-190 nM in MDCK cells, inhibits SARS-CoV-2 variants of concern. |
| PC-22714 |
Compound J1
Hemagglutinin inhibitor
|
Compound J1 is a small molecule compound targeting hemagglutinin (HA), inhibits influenza A virus and exhibits broad-spectrum antiviral activity against SARS-CoV-2, HSV1 and HSV2. |
| PC-22660 |
AV5116
Influenza virus inhibitor
|
AV5116 is a structural analogue of influenza virus endonuclease inhibitor baloxavir, and cap-dependent endonuclease (CEN) inhibitor. |
| PC-22659 |
AV5115
Influenza virus inhibitor
|
AV5115 is a structural analogue of influenza virus endonuclease inhibitor baloxavir, and cap-dependent endonuclease (CEN) inhibitor. |
